Wire flash
Hong Kong biotech stocks rise; Genscript Biotech up over 9%
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
On September 25, Hong Kong-listed biotech and pharmaceutical stocks moved higher in morning trading, according to a report from Chinese financial media outlet Cailianshe. Genscript Biotech Corporation led the gains, rising more than 9%. WuXi Biologics and WuXi AppTec each advanced over 2%. The brief market update reflects a positive session for the biotech sector in Hong Kong, though no specific catalyst or broader market context was provided in the report.
Source report
Hong Kong-listed biopharmaceutical stocks saw gains on September 25, with several key companies posting notable increases.
- Genscript Biotech Corporation rose over 9%
- WuXi Biologics gained more than 2%
- WuXi AppTec also rose over 2%
Source
财联社Eastern